MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Accurately distinguishing between different degenerative dementias during life is challenging but increasingly important with the prospect of disease-modifying therapies. Molecular biomarkers of dementia pathology are becoming available, but are not widely used in clinical practice. Conversely, structural neuroimaging is recommended in the evaluation of cognitive impairment. Visual assessment remains the primary method of scan interpretation, but in the absence of a structured approach, diagnostically relevant information may be under-utilized. This definitive, multi-centre study uses post-mortem confirmed cases as the gold standard to: (i) assess the reliability of six visual rating scales; (ii) determine their associated pattern of atrophy; (iii) compare their diagnostic value with expert scan assessment; and (iv) assess the accuracy of a machine learning approach based on multiple rating scales to predict underlying pathology. The study includes T1-weighted images acquired in three European centres from 184 individuals with histopathologically confirmed dementia (101 patients with Alzheimer's disease, 28 patients with dementia with Lewy bodies, 55 patients with frontotemporal lobar degeneration), and scans from 73 healthy controls. Six visual rating scales (medial temporal, posterior, anterior temporal, orbito-frontal, anterior cingulate and fronto-insula) were applied to 257 scans (two raters), and to a subset of 80 scans (three raters). Six experts also provided a diagnosis based on unstructured assessment of the 80-scan subset. The reliability and time taken to apply each scale was evaluated. Voxel-based morphometry was used to explore the relationship between each rating scale and the pattern of grey matter volume loss. Additionally, the performance of each scale to predict dementia pathology both individually and in combination was evaluated using a support vector classifier, which was compared with expert scan assessment to estimate clinical value. Reliability of scan assessment was generally good (intraclass correlation coefficient > 0.7), and average time to apply all six scales was <3 min. There was a very close association between the pattern of grey matter loss and the regions of interest each scale was designed to assess. Using automated classification based on all six rating scales, the accuracy (estimated using the area under the receiver-operator curves) for distinguishing each pathological group from controls ranged from 0.86-0.97; and from one another, 0.75-0.92. These results were substantially better than the accuracy of any single scale, at least as good as expert reads, and comparable to previous studies using molecular biomarkers. Visual rating scores from magnetic resonance images routinely acquired as part of the investigation of dementias, offer a practical, inexpensive means of improving diagnostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Visual assessment of scans using rating scales are reliable and offer diagnostic accuracy equivalent or better to unstructured scan evaluation by expert raters with an area under the curve (AUC) ranging from 0.67 to 0.97 for the differential diagnosis of different types of dementia [11, 13].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016 · cited 2×
“SVC processing and analysis was performed using the Python libraries SciPy 0.14.0 (Jones et al., 2001) and Scikit-Learn 0.15.2 (Pedregosa et al., 2011).”
MethodInfluentialIntraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532 · cited 1×
“As described by Shrout and Fleiss (1979), there are several forms of ICC, with the appropriate form determined by the underlying statistical model and the intended application of the reliability results.”
BackgroundData Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conference · doi:10.25080/majora-92bf1922-00a · Cited by 11,032 · cited 2×
“The time taken by each rater to apply the visual rating protocol to each image was automatically recorded to estimate the feasibility of implementing such a protocol in clinical practice.”
MethodInfluentialCortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910 · cited 8×
“This large, multi-centre study of pathologically proven dementias demonstrates that visual rating scales from routinely acquired structural MRIs are fairly reliable and highly correlated with cerebral atrophy in brain regions vulnerable to dementia pathology.”
MethodInfluentialThe NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381 · cited 1×
“All data processing and analyses were performed using Python libraries NumPy 1.8.1 (van der Walt et al., 2011), SciPy 0.14.0 (Jones et al., 2001) and Pandas 0.14.1 (McKinney, 2010) on Python 2.7.6 – 64-bit.”
MethodInfluentialA fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122 · cited 2×
“A group average tissue probability map was generated through iterative alignment of the initial segmentations to an evolving estimate of their group-wise average using the Dartel toolbox (Ashburner, 2007; Ashburner and Friston, 2009).”
MethodAshburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507 · cited 2×
“Cognitively normal control subjects (n = 73) were also included in the study.”
InfluentialSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“By contrast, structural neuroimaging is widely available and recommended as part of the clinical evaluation in all patients with suspected dementia [National Collaborating Centre for Mental Health (UK), 2006] and in the diagnostic criteria for a number of different dementias (Hort et al., 2010; Gorno-Tempini et al., 2…”
BackgroundSelf-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141 · cited 2×
“By contrast, structural neuroimaging is widely available and recommended as part of the clinical evaluation in all patients with suspected dementia [National Collaborating Centre for Mental Health (UK), 2006] and in the diagnostic criteria for a number of different dementias (Hort et al., 2010; Gorno-Tempini et al., 2…”
BackgroundSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation
Research works printed but not linked: 1
- Fumagalli, 2014, 9th International Conference on Frontotemporal Dementias P.252 Development of a visual rating scale for atrophy of the anterior cingulate, insula and frontal lobes, Am J Neurodegener Dis, 3, 1
Cited by
Items 101–200 of 262
Quintas-Neves, M., Almeida, F., Gauthreaux, K. M., Teylan, M., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2024) · Neuroradiology · doi:10.1007/s00234-024-03464-2 · Cited by 18
“In order to aid and increase acuity of the rating process, reference imagens for each rating scale were provided to the classifiers based on Harper et al. [9].”
InfluentialWang, Y., Lou, F., Li, Y., Liu, F., Wang, Y., Cai, L., Gordon, M. L., Zhang, Y., & Zhang, N. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211001113349 · Cited by 15
Venkatraghavan, V., Pascuzzo, R., Bron, E. E., Moscatelli, M. E. M., Grisoli, M., Pickens, A., Cohen, M. L., Schonberger, L. B., Gambetti, P. L., Appleby, B. S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12939 · Cited by 15
Topiwala, A., Suri, S., Allan, C. L., Valkanova, V., Filippini, N., Sexton, C. E., Heise, V., Zsoldos, E., Mahmood, A., Singh‐Manoux, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211273 · Cited by 16
“The Scheltens scale has been widely used and is well validated, is applicable to clinical settings, and aligns to some extent with volumetric measures in our sample [32, 35, 36].”
MethodMai, Y., Cao, Z., Zhao, L., Yu, Q., Xu, J., Liu, W., Liu, B., Tang, J., Luo, Y., Liao, W., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14492 · Cited by 13
Egger, K. E., Rau, A., Yang, S., Klöppel, S., Abdulkadir, A., Kellner, E., Frings, L., Hellwig, S., & Urbach, H. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146800 · Cited by 15
“Although visual rating scales are considered to evaluate gray matter volume loss, they are more or less based on the evaluation of widening of the corresponding brain sulci (Harper et al., 2016).”
Six Visual Rating Scales as A Biomarker for Monitoring Atrophied Brain Volume in Parkinson’s Disease
Lin, Y., Fu, Y., Zeng, Y.-F., Hu, J., Lin, X., Cai, N., Weng, Q., Zhao, Y., Lin, Y., Cao, D., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.1103 · Cited by 13
“Both a visual rating scale and brain volume analysis was performed in rare studies[7, 9, 10].”
BackgroundMethodShin, J. H., Kim, H., Kim, Y. K., Yoon, E. J., Nam, H., Jeon, B., & Lee, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00356-y · Cited by 14
Granadillo, E. D., Paholpak, P., Mendez, M. F., & Teng, E. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477718 · Cited by 12
An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis
Durmuş, H., Çakar, A., Demirci, H., Alaylıoğlu, M., Gezen‐Ak, D., Dursun, E., & Parman, Y. (2021) · Acta Neurologica Scandinavica · doi:10.1111/ane.13507 · Cited by 12
Ssali, T., Narciso, L., Hicks, J. W., Liu, L., Jesso, S., Richardson, L., Günther, M., Konstandin, S., Eickel, K., Prato, F. S., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102950 · Cited by 13
“This method is similar to visual rating scales where regional atrophy is identified within disease specific ROI (Harper et al., 2016).”
MethodDiverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease
Sakurai, K., Kaneda, D., Morimoto, S., Uchida, Y., Inui, S., Kimura, Y., Cai, C., Kato, T., Ito, K., & Hashizume, Y. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.11.001 · Cited by 12
Brett, B. L., Wilmoth, K., Cummings, P., Solomon, G. S., McCrea, M., & Zuckerman, S. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181058 · Cited by 15
Transcranial Sonography Findings in Alzheimer’s Disease: A New Imaging Biomarker
Yılmaz, R., Granert, O., Schäffer, E., Jensen‐Kondering, U., Schulze, S., Bartsch, T., & Berg, D. (2020) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/a-1146-3036 · Cited by 13
“[7] reached the highest accuracy with regard to discriminating AD from controls [10].”
BackgroundThe Parietal Atrophy Score on Brain Magnetic Resonance Imaging is a Reliable Visual Scale
Šilhán, D., Bartoš, A., Mrzílková, J., Pashkovska, O., Ibrahim, I., & Tintěra, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200807193957 · Cited by 16
“Visual scales represent a simple option to evaluate brain atrophy quickly and thus are more suitable for clinical practice [22-24].”
Siddiqui, T. G., Whitfield, T. J., Praharaju, J., Sadiq, D., Kazmi, H., Ben-Joseph, A., & Walker, Z. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000510951 · Cited by 13
Chu, C., Pan, W., Ren, Y., Mao, P., Yang, C., Liu, C., & Tang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1243894 · Cited by 13
“The utilization of Schelten’s scale has exhibited comparable precision in differentiating between healthy individuals and those afflicted with AD, as automated measurement methods (27, 28).”
MethodAssociation between Female Reproductive Factors and Risk of Dementia
Pszczołowska, M., Walczak, K., Miśków, W., Mroziak, M., Kozłowski, G., Beszłej, J. A., & Leszek, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102983 · Cited by 15
“Neu-roimages obtained thanks to magnetic resonance imaging (MRI) or computer tomography (CT) help to visualize atrophy of the brain structures [32–34].”
BackgroundSakurai, K., Tokumaru, A. M., Yoshida, M., Saito, Y., Wakabayashi, K., Komori, T., Hasegawa, M., Ikeuchi, T., Hayashi, Y., Shimohata, T., et al. (2024) · Neuroradiology · doi:10.1007/s00234-024-03432-w · Cited by 12
“A previous study has already clarified the close correlation between the regional gray matter atrophy on VBM and visual assessment on visual rating scales [38].”
BackgroundKoberskaya, N. N. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-10-18-24 · Cited by 15
Resende, E. D. P. F., Hornberger, M., Guimarães, H. C., Gambogi, L. B., Mariano, L. I., Teixeira, A. L., Caramelli, P., & de Souza, L. C. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5503 · Cited by 12
“For instance, using a grading system to visually rate parietal and orbitofrontal atrophy worked better to differentiate AD from frontotemporal lobe degeneration.(38) In our study, visual–verbal episodic memory impairment correlated with bilateral hippocampal atrophy, both in bvFTD and AD patients suggesting that the v…”
Pinho, J., Almeida, F., Araújo, J. M., Machado, Á. S., Costa, A. S., Silva, F., Francisco, A., Quintas-Neves, M., Ferreira, M. D. C., Soares-Fernandes, J. P., et al. (2023) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7900 · Cited by 12
Kaskikallio, A., Karrasch, M., Rinne, J. O., Tuokkola, T., Parkkola, R. K., & Grönholm-Nyman, P. (2019) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2019.1628916 · Cited by 13
“However, these quantitative methods have not been integrated into clinical work and visual rating scales still remain the primarymethods for obtaining diagnostic information in a clinical context (Harper, Barkhof, Fox, & Schott, 2015; Harper et al., 2016).”
MethodStructural brain imaging as a diagnostic tool in dementia, why and how?
Wahlund, L. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111183 · Cited by 18
Vanhoenacker, A.-S., Sneyers, B., Keyzer, F. D., Heye, S., & Demaerel, P. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0777-8 · Cited by 11
Aetiology and pathophysiology of neurodegenerative disorders
Sahoo, R. K., Gupta, T., Smily, Kumar, V., Rani, S., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00006-x · Cited by 19
Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research
Shoemaker, R. L., Larsen, R. J., & Larsen, P. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426656 · Cited by 13
Medial temporal atrophy predicts the limbic comorbidities in lewy body disease
Sakurai, K., Kaneda, D., Morimoto, S., Uchida, Y., Inui, S., Shang, C., Kimura, Y., Cai, C., Kato, T., Ito, K., et al. (2024) · Neuroradiology · doi:10.1007/s00234-024-03502-z · Cited by 10
“It is known that the limbic and temporal lobes are infrequently impaired in patients with LBD [32–34].”
Functional Imaging for Neurodegenerative Diseases
Chollet, F., & Payoux, P. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104121 · Cited by 11
MRI biomarkers — a precision medicine tool in neurology?
McMillan, C. T. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.51 · Cited by 11
Multi-view visual saliency-based MRI classification for alzheimer's disease diagnosis
Ahmed, O. B., Lecellier, F., Paccalin, M., & Fernández-Maloigne, C. (2017) · International Conference on Image Processing Theory, Tools and Applications (IPTA) · doi:10.1109/ipta.2017.8310118 · Cited by 10
“The development and analysis of visual features in medical imaging have been extensively studied earlier [7]–[11] In clinical practice, visual assessment and analysis is the most widely used method for brain atrophy evaluation [12].”
MethodPD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies
Berman, S., & Miller‐Patterson, C. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.009 · Cited by 14
Sakurai, K., Morimoto, S., Oguri, T., Yuasa, H., Uchida, Y., Yamada, K., Muto, M., Saito, Y., Aiba, I., Takao, M., et al. (2019) · Neuroradiology · doi:10.1007/s00234-019-02289-8 · Cited by 10
Šilhán, D., Initiative, A. D. N., Pashkovska, O., & Bartoš, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210372 · Cited by 10
Wan, M.-D., Liu, H., Liu, X.-X., Zhang, W., Xiao, X., Zhang, S.-Z., Jiang, Y., Zhou, H., Liao, X., Zhou, Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.906519 · Cited by 10
Tseriotis, V., Mavridis, T., Eleftheriadou, K., Konstantis, G., Chlorogiannis, D., Pavlidis, P., Pourzitaki, C., Arnaoutoglou, M., & Spyridon, K. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12381-6 · Cited by 10
“Nevertheless, in a multicenter investigation incorporating autopsy confirmation, the use of MTL atrophy as a biomarker to differentiate AD from DLB demonstrated sensitivity and specificity at only 64% and 68%, respectively [34].”
A visual scale to rate amygdalar atrophy on MRI
Pizzini, F. B., Ribaldi, F., Natale, V., Scheffler, M., Rossi, V., & Frisoni, G. B. (2024) · European Radiology · doi:10.1007/s00330-024-11249-7 · Cited by 11
Zilioli, A., Rosenberg, A., Mohanty, R., Matton, A., Granberg, T., Hagman, G., Lötjönen, J. M. P., Kivipelto, M., & Westman, E. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12853-9 · Cited by 10
Sheng, C., Sun, Y., Wang, M., Wang, X., Liu, Y. F., Pang, D., Liu, J., Bi, X., Du, W., Zhao, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200016 · Cited by 8
“However, due to the long processing time and dependency on specific algorithms in MRI quantitative analysis, brain morphological measurements have not yet been widely applied in routine clinical work [16].”
Sakurai, K., Kaneda, D., Morimoto, S., Uchida, Y., Inui, S., Kimura, Y., Kato, T., Ito, K., & Hashizume, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230441 · Cited by 9
Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson’s Disease and Aging
Gathings, A., Zaman, V., Banik, N. L., & Haque, A. (2024) · Biomedicines · doi:10.3390/biomedicines12051074 · Cited by 9
“The major pathological difference between AD and DLB detected by imaging is that medial temporal lobe atrophy is less severe in patients with DLB when compared to AD [29,100].”
BackgroundChun, M. Y., Kim, G. H., Park, H. K., Yang, D. W., Kim, S., Choi, S. H., & Jeong, J. H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123433 · Cited by 11
“to recognize amyloid PET positivity in aMCI subjects, consistent with those of previous studies [23,60,61].”
ResultClinical Translation of Integrated PET ‐ MRI for Neurodegenerative Disease
Shepherd, T. M., & Dogra, S. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70046 · Cited by 11
Utility of visual rating scales in primary progressive aphasia
Falgàs, N., Sacchi, L., Carandini, T., Montagut, N., Conte, G., Triulzi, F. M., Galimberti, D., Arighi, A., Sánchez‐Valle, R., & Fumagalli, G. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01442-7 · Cited by 8
Self-citationA machine learning approach for identifying anatomical biomarkers of early mild cognitive impairment
Ahmad, A. L., Sánchez‐Bornot, J. M., Sotero, R. C., Coyle, D., Idris, Z., & Faye, I. (2024) · PeerJ · doi:10.7717/peerj.18490 · Cited by 12
Structural imaging in dementia with Lewy bodies: the potential of multivariate data analysis
Ferreira, D. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111180 · Cited by 8
Potential markers for sample size estimations in hereditary spastic paraplegia type 5
Lin, Q., Liu, Y., Ye, Z., Hu, J., Cai, W., Weng, Q., Chen, W., Wang, N., Cao, D., Lin, Y., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02014-w · Cited by 9
Daño vascular y rendimiento cognitivo-funcional en una población con deterioro cognitivo leve
Labos, E., Guajardo, M. E., Söderlund, M. E., Pagotto, V. L., Sagues, X., Seinhart, D. B., & Schapira, M. C. (2022) · Revista de Neurología · doi:10.33588/rn.7407.2021411 · Cited by 13
“La escala visual de Fazekas tiene una alta con-fiabilidad en la evaluación de la patología de la sus-tancia blanca y una buena correlación con las me-didas cognitivas [6], y se ha usado ampliamente en la investigación clínica.”
BackgroundDang, M., Liu, B., Chen, Y., & Zhang, Z. (2026) · Psychoradiology · doi:10.1093/psyrad/kkag007 · Cited by 10
Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects
Blanc, F., & Bousiges, O. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.008 · Cited by 11
Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies—Current View
Jellinger, K. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167674 · Cited by 8
“Although medial temporal atrophy can be supportive in distinguishing between DLB and AD [62,63], in DLB/AD+ cases, it is more severe than in DLB/AD − ones [59,64].”
Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism
Brooks, D. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00994-4 · Cited by 7
Parkinson's disease fluid biomarkers for differential diagnosis of atypical parkinsonian syndromes
Yang, J., Idowu, A., Rosenthal, L. S., & Mao, X. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.150 · Cited by 7
Neupane, S., & Hortobágyi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411811 · Cited by 6
Calloni, S. F., Vezzulli, P. Q., Castellano, A., Leone, R., Basaia, S., von Loon, A., Spinelli, E. G., Magnani, G., Caso, F., Agosta, F., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03133-w · Cited by 6
Tuovinen, T., Häkli, J., Rytty, R., Krüger, J., Korhonen, V. O., Järvelä, M., Helakari, H., Kananen, J., Nikkinen, J., Veijola, J., et al. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241262583 · Cited by 5
“26 The sensitivity of the criteria for possible bvFTD ranges from 75% to 95%, and for probable bvFTD from 64% to 85%.”
InfluentialThalamic Deep Brain Stimulation for tremor: The critical role of intraoperative testing
Mahajan, A., Bader, A., Wang, L., Rekhtman, A., Espay, A. J., Dwivedi, A. K., Sturchio, A., Marsili, L., Duker, A. P., Krishna, V., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.03.022 · Cited by 6
Barber, P., Schaeffer, M. J., & Chan, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303011 · Cited by 6
“(Harper et al., 2016).”
Blain, A., Sellal, F., Philippi, N., Blanc, F., & Cretin, B. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106736 · Cited by 6
Brain atrophy pattern in patients with mild cognitive impairment: MRI study
Calandrelli, R., Panfili, M., Onofrj, V., Tran, H. E., Piludu, F., Guglielmi, V., Colosimo, C., & Pilato, F. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0248 · Cited by 8
“Visual rating scales provide semiquantitative measures of the degree of atrophy in sectorized brain regions, evaluating structures and liquor spaces of one or more neighboring lobes [16,17].”
BackgroundNeuropsychological impact of white matter hyperintensities in older adults without dementia
Chavda, R., Cao, J. S., & Benge, J. F. (2019) · Applied Neuropsychology Adult · doi:10.1080/23279095.2019.1633536 · Cited by 7
“Visual rating scales such as Junque Scale of Leukoaraiosis or Cardiovascular Health Study Scale for WMH are widely available (Harper et al., 2016; Junqu e et al., 1990; Kuller et al., 2004), but have been criticized for variable reliability among raters (M€aNtyl€a et al., 1997) and for…”
MethodA longitudinal observation of brain structure between AD and FTLD
Li, J., Fan, Y., Hou, B., Huang, X., Lei, D., Wang, J., Mao, C., Dong, L., Liu, C., Feng, F., et al. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106604 · Cited by 6
Gil, N., Tabari, A., Nickel, D. M., Lo, W., Clifford, B., Cauley, S., Lang, M., Buathong, S., Hajati, A., Fujita, S., et al. (2025) · Radiology Advances · doi:10.1093/radadv/umaf022 · Cited by 5
“…regions (the anterotemporal, cingulate, frontoinsular, medial-temporal, orbitofrontal, and posterior regions) based on a standardized rating scale, 23 which assigns integer scores of either 0–3 or 0– 4 depending on the anatomical region, with higher numbers correlating to greater volume loss, and…”
Fornari, C., & Fumagalli, G. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0066 · Cited by 5
“The scale di ff erentiates fairly accurately between FTD patients, and between AD and HC.”
InfluentialSelf-citationCoulborn, S., Roy, A. R. K., Sokołowski, A., Cryns, N. G., Lago, A. L., Cobigo, Y., Rojas, J. C., Spina, S., Grinberg, L. T., Rankin, K. P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70771 · Cited by 6
Automated Volumetric Software in Dementia: Help or Hindrance to the Neuroradiologist?
Tanabe, J., Lim, M., Dash, S., Pattee, J. W., Steach, B., Pressman, P., Bettcher, B. M., Honce, J. M., Potigailo, V., Colantoni, W., et al. (2024) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8406 · Cited by 6
Totuk, Ö., & Şahin, Ş. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061822 · Cited by 8
“The assessment is usually performed on T1-J weighted coronal or axial sequences of MRI where experienced raters visually inspect the OF region [26] (Box 4).”
MRI for diagnosing dementia – update 2025
Akl, E., Dyrba, M., Göerß, D., Schumacher, J., & Weber, M. (2025) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-2563-0725 · Cited by 8
“Subcortical atrophy and hyperintensities observed on MRI are key features in Parkinson ’ s disease dementia and DLB, with notable changes in the basal ganglia and brainstem regions [19].”
Goldman, J. G., Boeve, B. F., Galasko, D. R., Taylor, J., Galvin, J. E., Leverenz, J. B., Blanc, F., Halliday, G. M., Kantarci, K., Lemstra, A. W., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70470 · Cited by 6
“99,100 Basal forebrain changes on brain MI support evidence of cholinergic neurodegeneration in DLB. 85”
Self-citationYang, B., Luo, C., Yu, M., Zhou, L., Bo, T., Tang, B., Zhou, Y., Zhu, J., Huang, M., Peng, F., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.573512 · Cited by 5
Fan, X., Cai, Y., Zhao, L., Liu, W., Luo, Y., Au, L. W. C., Shi, L., & Mok, V. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230574 · Cited by 5
van Gils, A. M., Tolonen, A. J., Rhodius‐Meester, H. F. M., Mecocci, P., Vanninen, R. L., Frederiksen, K. S., Barkhof, F., Jasperse, B., Lötjönen, J. M. P., van der Flier, W. M., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11257-7 · Cited by 4
Self-citationChoe, Y. S., Kim, R. E. Y., Kim, H. W., Kim, J. Y., Lee, H., Lee, M. K., Lee, M., Kim, K. Y., Kim, S., Kim, J., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230105 · Cited by 4
Rojas, G., David Ladrón de Guevara, H., Rodrigo Jaimovich, F., Brunetti, E. P., Faure, E., & Marcelo Gálvez, M. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.06.008 · Cited by 19
Medial Temporal Atrophy Alone is Insufficient to Predict Underlying Alzheimer’s Disease Pathology
Jeong, H. E., Shin, D. H., & Lee, D. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.18.0144 · Cited by 4
Tavakoli, H. M., Xie, T., Shi, J., Hadžikadić, M., & Ge, Y. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313561 · Cited by 4
“Other studies [5] [6] estimated the progression using the volumetric measures of the brain subregions using three-dimensional imaging techniques.”
Method„Big Data“ und künstliche Intelligenz zur Diagnoseunterstützung bei atypischer Demenz
Egger, K. E., & Rijntjes, M. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0568-3 · Cited by 6
Lifespan Tree of Brain Anatomy: Diagnostic Values for Motor and Cognitive Neurodegenerative Diseases
Coupé, P., Mansencal, B., Manjón, J. V., Péran, P., Meissner, W. G., Tourdias, T., & Planche, V. (2025) · Human Brain Mapping · doi:10.1002/hbm.70336 · Cited by 3
Escobar-López, M., & Salazar-Varas, R. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108733 · Cited by 5
Aranha, M. R., Coutinho, A. M., Carneiro, C. D. G., Pastorello, B., Studart‐Neto, A., Guariglia, C., Tsunemi, M. H., Moreira, E. L. S., Ianof, J. N., Anghinah, R., et al. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1768666 · Cited by 4
The interplay between gut microbiota composition and dementia
Pour, R. G. K., Zounouzi, S. K., Farshbafnadi, M., & Rezaei, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0113 · Cited by 3
Application of scales and questionnaires in clinical medicine
Kazimirova, O. V., Yugay, M. N., Zhaparkul, B. D., Батырбекова, Л. С., Уахитова, Ж. Т., & Lenkovets, N. A. (2023) · Medicine and ecology · doi:10.59598/me-2305-6045-2023-109-4-5-24 · Cited by 4
Emerging Trends of Artificial Intelligence in Detecting Neurodegeneration
Singh, D. P., Kaushik, B., Khan, Y. F., Chadha, A., Mahajan, A., Jandwani, A., & Narula, G. S. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-97-2550-2_42 · Cited by 3
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales
Fornari, C., Meli, C., Rabini, G., Funghi, G., Speranza, C., Pierotti, E., Hubner, S., Ottaviani, D., Giacopo, R. D., Malaguti, M. C., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08311-7 · Cited by 3
Self-citationAbbate, C., Trimarchi, P. D., Fumagalli, G., Gallucci, A., Tomasini, E., Fracchia, S., Rebecchi, I., Morello, E., Fontanella, A., Parisi, P. M. R., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220919 · Cited by 4
Self-citationKameyama, M., Ishibashi, K., Toyohara, J., Wagatsuma, K., Umeda‐Kameyama, Y., Shimoji, K., Kanemaru, K., Murayama, S., Ogawa, S., Tokumaru, A. M., et al. (2020) · Aging · doi:10.18632/aging.104012 · Cited by 2
“typical AD, hippocampal-sparing AD, and limbic-predominant AD [36], and to distinguish nonAD degenerative dementia from MCI due to AD [37, 38].”
BackgroundZilioli, A., Misirocchi, F., Pancaldi, B., Mutti, C., Ganazzoli, C., Morelli, N., Pellegrini, F. F., Messa, G., Scarlattei, M., Mohanty, R., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.122806 · Cited by 2
“Although partially automatic and automatic methods have demonstrated impressive accuracy, their implementation in routine clinical practice poses challenges due to time constraints [9,10].”
Matsusue, E., Inoue, C., Shimoda, M., Nakamura, T., Matsumoto, S., Matsumoto, K., Tanino, T., Nakamura, K., & Fujii, S. (2024) · Acta Radiologica · doi:10.1177/02841851241253775 · Cited by 2
“A multisite study with autopsy con fi rmation differentiated DLB from AD with an accuracy of 66% (23).”
Socher, K. L. R., Nunes, D. M., Lopes, D., Coutinho, A. M., Faria, D. D. P., Squarzoni, P., Busatto, G. F., Buchpiguel, C. A., Nitríni, R., & Brucki, S. M. D. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1802960 · Cited by 4
“In 2016, Harper et al. 8 compared the visual classi fi cation scores in the diagnosis of dementia; MTA was positively associated with loss of hippocampus volume and provided a reliable score to identify late-onset AD.”
Chronic apathy following a major depressive episode: What is it?
Morin, A., Bernard, J., Carle, G., Ponchel, A., Azuar, C., Uggocioni, G., Mauras, T., Bendetowicz, D., Camus, M., Delcul, A., et al. (2025) · Cortex · doi:10.1016/j.cortex.2025.04.008 · Cited by 3
What to make of equivocal amyloid imaging results
Burrell, J. R., Foxe, D., Leyton, C. E., Piguet, O., & Hodges, J. R. (2020) · Neurocase · doi:10.1080/13554794.2020.1764056 · Cited by 2
Laczó, J., Hort, J., & Vyhnálek, M. (2021) · Neurologie pro praxi · doi:10.36290/neu.2021.026 · Cited by 2
Disentangling Reversal-learning Impairments in Frontotemporal Dementia and Alzheimer Disease
Ahmed, K., Mitchell, D. G. V., Blair, M., Coleman, K. K. L., Pasternak, S., Ruiz‐Garcia, R., & Finger, E. C. (2022) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000303 · Cited by 3
“…made by E.F. based on a review of available brain images and clinical imaging reports (MRI or CT) and was complemented by a visual rating scale score for FTD (Harper et al, 2016) that was completed by a physician (R.R.-G.) who was blinded to the study design, hypothesis, and participant diagnoses.”
MethodYuan, Q., Yang, J., Xian, Y., Liu, R., Chan, C. W., Wu, W., & Lin, Z. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200807191447 · Cited by 2
Polat, B., Yılmaz, N. H., Bilgin, S. Ş., & Hanoğlu, L. (2020) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.737253 · Cited by 1
An Overview on Dementia: A Major Symptom of Alzheimer's Disease
Kaur, J., Melkani, I., Singh, A., Singh, A. P., & Bala, K. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i4.5445 · Cited by 2
Atrofia cortical precoz en el trastorno de conducta del sueño REM
Abildúa, M. J. A., Santos, E. L., Domínguez, L. M., Álvarez‐Santullano, M. M., Fernández, C. B., Cortés, I. P., Rodriguez, R. L., Barrero, F. J. N., Ubierna, S. M., Gómez‐Aceña, Á., et al. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.02.014 · Cited by 1
Naftali, J., Keret, O., Manor, O., Glik, A., Barnea, R., Bloch, S., Spectre, G., Leader, A., Saliba, W. I., & Auriel, E. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123460 · Cited by 2
Wang, B., Zhao, T., Ma, R., Huo, X., Xiong, X., Wu, M., Wang, Y., Liu, L., Zhuang, Z., Wang, B., et al. (2025) · JMIR Aging · doi:10.2196/76981 · Cited by 1
“This meta-analysis confirms that AI-enhanced sMRI and 18 F-FDG PET achieve high diagnostic accuracy for AD, with pooled SROC-AUCs of 0.94 and 0.96, respectively, outperforming conventional visual assessments [61,62].”
Influential
Metadata
- Authors
- Harper, L., Fumagalli, G. G., Barkhof, F., Scheltens, P., O’Brien, J. T., Bouwman, F., Burton, E. J., Rohrer, J. D., Fox, N. C., Ridgway, G. R., & Schott, J. M.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- University of Milan (IT)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Newcastle Hospitals - Campus for Ageing and Vitality (GB)
- Wellcome Centre for Human Neuroimaging (GB)
- Corresponding author
- Schott, Jonathan M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-01
- Volume
- 139
- Issue
- 4
- Pages
- 1211-1225
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4806219
- OpenAlex
- W2289713178
- Cited by
- 264
- References
- 60
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 30 · 2023: 21 · 2022: 28 · 2021: 33 · 2020: 34 · 2019: 33 · 2018: 16 · 2017: 18 · 2016: 7
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10134, NF-SI-0508-10123, CL-2012-18-010)
- Medical Research Council (MR/J014257/2, MR/M008525/1)
- Engineering and Physical Sciences Research Council (EP/J020990/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiology practices and education
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia diagnosis, Alzheimer's disease, dementia with Lewy bodies, frontotemporal lobar degeneration, gray matter atrophy, T1-weighted imaging, rating scale reliability, machine learning classification, support vector classifier, postmortem histopathology, structural neuroimaging, disease-modifying therapy, molecular biomarkers, voxel-based morphometry
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Autopsy, Cerebral Cortex, Dementia, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Reproducibility of Results, Lewy Body Disease, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.